STOCK TITAN

Quince Therapeutics, Inc. (QNCX) Net Income by Year

QNCX

Quince Therapeutics, Inc. reported a net loss of $84.0M in fiscal year 2025. This represents a decrease of 47.8% from the prior fiscal year. The table below carries 8 fiscal years, from 2018 to 2025, and the quarters Quince Therapeutics, Inc. has filed alongside them.

FY2025 annual
Net Income -$84.0M
YoY -47.8%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

QNCX Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY25DEF 14AFY24DEF 14AFY23DEF 14AFY2210-KFY2110-KFY2010-KFY1910-KFY1810-K
Net Income-$84.0M-47.8%-$56.8M-81.0%-$31.4M+39.2%-$51.7M+42.6%-$89.9M-17.0%-$76.8M-107.8%-$37.0M-196.4%-$12.5M

QNCX Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Net Income-$75.5M-370.4%$35.9M+338.9%N/A-$13.4M-144.8%-$16.0M+42.1%-$15.0M-34.8%N/A-$5.5M-2.6%-$27.7M-467.5%-$11.1M+9.0%N/A-$5.4M+32.4%

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More Quince Therapeutics, Inc. financials

Frequently Asked Questions

What was Quince Therapeutics, Inc.'s net income in fiscal year 2025?

Quince Therapeutics, Inc. reported a net loss of $84.0M in fiscal year 2025.

How fast is Quince Therapeutics, Inc.'s net income growing?

Quince Therapeutics, Inc. (QNCX) net income fell by 47.8% year over year, from -$56.8M to -$84.0M in fiscal year 2025.

How has Quince Therapeutics, Inc.'s net income changed over the years?

Across the 8 fiscal years this page covers, Quince Therapeutics, Inc. (QNCX) net income went from -$12.5M in fiscal year 2018 to -$84.0M in fiscal year 2025.

Quince Therapeutics, Inc. (QNCX) reported -$75.5M in net income in Q2 2026. This represents a decrease of 370.4% from the same quarter a year earlier.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Quince Therapeutics, Inc. (QNCX) reported on that line in every period on record.